Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Latvia,Lithuania,Hungary,Croatia,Slovakia,France,Finland,Ukraine,United States,Czech Republic
nct
Update Il y a 5 ans
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension
The objective of the current study is to investigate the safety and efficacy of BI 10773 in 2 different doses compared to Metformin or to Sitagliptin given for 78 weeks in different modalities of treatment in patients with type 2 diabetes mellitus.
Country
Austria
,
Croatia
,
Czech Republic
,
Estonia
,
Finland
,
France
,
Germany
,
Hungary
,
Italy
,
Korea, Republic of
,
Latvia
,
Lithuania
,
Norway
,
Romania
,
Russian Federation
,
Slovakia
,
Spain
,
Sweden
,
Taiwan, Province of China
,
Ukraine
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
An open ended study in which patients who completed the double-blind study CDP870-027 [NCT00152386] are given Certolizumab Pegol (CZP) and assessed for signs and symptoms of Rheumatoid Arthritis (RA).
Country
Argentina
,
Australia
,
Belgium
,
Bulgaria
,
Canada
,
Chile
,
Croatia
,
Czech Republic
,
Estonia
,
Finland
,
France
,
Hungary
,
Israel
,
Latvia
,
Lithuania
,
Mexico
,
New Zealand
,
Russian Federation
,
Serbia
,
Slovakia
,
Ukraine
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1